PGEN RSI Chart
Last 7 days
-1.5%
Last 30 days
-4.2%
Last 90 days
-2.9%
Trailing 12 Months
12.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 23.2M | 22.1M | 0 | 0 |
2022 | 16.3M | 15.4M | 28.8M | 26.9M |
2021 | 97.9M | 71.2M | 51.0M | 35.3M |
2020 | 98.0M | 95.6M | 100.8M | 103.2M |
2019 | 134.1M | 121.7M | 107.5M | 90.7M |
2018 | 217.1M | 208.0M | 194.4M | 151.2M |
2017 | 201.2M | 203.2M | 200.2M | 231.2M |
2016 | 183.2M | 190.8M | 186.4M | 190.9M |
2015 | 97.9M | 131.0M | 163.2M | 173.6M |
2014 | 27.7M | 32.8M | 48.0M | 71.9M |
2013 | 16.1M | 20.1M | 23.2M | 23.8M |
2012 | 9.5M | 10.9M | 12.3M | 13.8M |
2011 | 0 | 0 | 0 | 8.0M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 02, 2024 | kirk randal j | sold | - | - | -8,790,670 | - |
May 02, 2024 | perez jeffrey thomas | acquired | - | - | 126,713 | svp, ip affairs |
May 02, 2024 | kirk randal j | sold | - | - | -4,995,000 | - |
May 02, 2024 | kirk randal j | sold | - | - | -1,383,860 | - |
May 02, 2024 | kirk randal j | sold | - | - | -58,800 | - |
May 02, 2024 | kirk randal j | sold | - | - | -59,133 | - |
May 02, 2024 | kirk randal j | sold | - | - | -2,497,500 | - |
May 02, 2024 | kirk randal j | sold | - | - | -832,500 | - |
May 02, 2024 | kirk randal j | sold | - | - | -118,266 | - |
May 02, 2024 | kirk randal j | acquired | - | - | 8,896,410 | - |
Which funds bought or sold PGEN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 13, 2024 | UBS Group AG | reduced | -20.81 | -41,128 | 246,377 | -% |
May 13, 2024 | ENVESTNET ASSET MANAGEMENT INC | added | 40.33 | 8,508 | 24,918 | -% |
May 13, 2024 | Ameritas Investment Partners, Inc. | unchanged | - | 1,490 | 19,636 | -% |
May 13, 2024 | CANADA LIFE ASSURANCE Co | added | 15.03 | 2,000 | 10,000 | -% |
May 13, 2024 | HRT FINANCIAL LP | sold off | -100 | -16,000 | - | -% |
May 13, 2024 | STRS OHIO | reduced | -5.98 | 1,000 | 68,000 | -% |
May 13, 2024 | FRANKLIN RESOURCES INC | unchanged | - | 6,647 | 87,611 | -% |
May 13, 2024 | FMR LLC | reduced | -0.11 | 27,744 | 370,671 | -% |
May 13, 2024 | XTX Topco Ltd | sold off | -100 | -88,657 | - | -% |
May 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | added | 20.35 | 354,000 | 1,526,000 | -% |
Unveiling Precigen Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Precigen Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 49.2B | 6.8B | -8.24 | 7.18 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.7B | 2.0B | -56.37 | 9.34 | ||||
BMRN | 15.1B | 2.5B | 73.61 | 6.12 | ||||
INCY | 12.8B | 3.8B | 17.19 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.4B | 107.9M | -9.91 | 48.09 | ||||
APLS | 5.0B | 524.1M | -11.98 | 9.54 | ||||
AXSM | 3.7B | 251.0M | -12.39 | 14.63 | ||||
ARWR | 2.8B | 240.7M | -6.04 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.4K | 3.02 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.9B | 996.6M | -4.75 | 1.9 | ||||
CRBP | 456.3M | 881.7K | -13.52 | 481.06 | ||||
INO | 297.2M | 4.9M | -2.38 | 61.07 | ||||
IBIO | 16.2M | 2.1M | -0.7 | 7.61 |
Precigen Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -4.5% | 1,767,000 | 1,851,000 | 1,763,000 | 16,722,000 | 2,911,000 | 5,513,000 | 3,684,000 | 3,333,000 | 3,815,000 | 24,511,000 | 19,333,000 | 23,583,000 | 30,424,000 | 29,838,000 | 17,002,000 | 18,299,000 | 32,836,000 | 22,585,000 | 33,789,000 | 32,448,000 | 45,275,000 |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 92,000 | -37,480,500 | 2,480,000 | 2,200,000 | 82,038,000 | -273,472,500 | 98,919,000 | 95,010,000 |
S&GA Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 24,741,000 | 21,483,000 | 33,594,000 | 24,935,000 | 38,708,000 | 34,427,000 |
R&D Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31,480,000 | 34,518,000 | 33,062,000 | 280,449,500 | 44,885,000 | 42,049,000 |
EBITDA Margin | 0.8% | -2.78 | -2.80 | -2.31 | -2.45 | -5.59 | -5.40 | -2.43 | -1.91 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | -85.3% | 136,000 | 924,000 | 624,500 | 2,036,000 | 2,063,000 | 3,535,000 | -2,871,500 | 4,765,000 | 4,633,000 | 3,539,000 | -2,778,500 | 4,646,000 | 4,592,000 | 3,568,000 | -2,546,000 | 4,466,000 | 4,353,000 | 77,000 | -372,000 | 3,999,000 | 142,000 |
Income Taxes | -18.2% | -65,000 | -55,000 | 8,000 | -50,000 | -89,000 | -58,000 | -164,000 | - | - | 4,000 | -130,000 | 8,000 | - | 40,000 | -451,500 | -512,000 | -525,000 | 30,000 | 4,110,000 | -14,322,000 | -1,127,000 |
Earnings Before Taxes | 10.6% | -20,384,000 | -22,789,000 | -22,168,000 | -7,694,000 | -26,148,000 | -23,956,000 | -29,188,500 | -26,380,000 | -30,999,000 | -21,896,000 | -40,303,000 | -27,586,000 | -15,829,000 | -20,806,000 | -36,980,000 | -49,057,000 | -32,314,000 | -52,913,000 | -203,393,000 | -73,068,000 | -67,956,000 |
EBT Margin | 2.5% | -3.30 | -3.39 | -2.97 | -3.02 | -6.84 | -6.76 | -3.07 | -2.35 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | 10.6% | -20,319,000 | -22,734,000 | -22,176,000 | 87,379,000 | -17,635,000 | -19,251,000 | -25,034,000 | -29,764,000 | -20,050,000 | -17,318,000 | -41,661,000 | -29,508,000 | -43,354,000 | -55,998,000 | -169,215,000 | -53,634,000 | -38,766,000 | -60,709,000 | -340,465,000 | -57,324,000 | -65,382,000 |
Net Income Margin | -6.2% | 1.00 | 1.07 | 1.05 | 0.88 | -5.94 | -5.76 | -2.61 | -2.13 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 14.4% | -15,869,000 | -18,542,000 | -15,449,000 | -25,387,000 | -8,771,000 | -20,362,000 | -17,362,000 | -19,288,000 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -10.7% | 135 | 151 | 191 | 208 | 242 | 216 | 259 | 321 | 336 | 360 | 377 | 403 | 407 | 315 | 336 | 362 | 405 | 456 | 605 | 655 | 710 |
Current Assets | -27.9% | 50.00 | 69.00 | 93.00 | 106 | 138 | 118 | 163 | 165 | 155 | 157 | 153 | 157 | 144 | 149 | 151 | 173 | 189 | 235 | 157 | 183 | 232 |
Cash Equivalents | 134.1% | 18.00 | 8.00 | 10.00 | 17.00 | 10.00 | 5.00 | 92.00 | 50.00 | 41.00 | 43.00 | 42.00 | 37.00 | 28.00 | 52.00 | 28.00 | 47.00 | 38.00 | 68.00 | 45.00 | 59.00 | 107 |
Net PPE | 77.5% | 13.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 8.00 | 8.00 | 34.00 | 9.00 | 33.00 | 33.00 | 34.00 | 35.00 | 45.00 | 47.00 | 60.00 | 44.00 | 123 | 120 | 136 |
Goodwill | -0.2% | 27.00 | 27.00 | 37.00 | 37.00 | 37.00 | 37.00 | 37.00 | 37.00 | 54.00 | 38.00 | 54.00 | 54.00 | 54.00 | 38.00 | 54.00 | 54.00 | 64.00 | 54.00 | 148 | 150 | 151 |
Liabilities | 16.2% | 38.00 | 33.00 | 43.00 | 41.00 | 57.00 | 90.00 | 117 | 266 | 262 | 253 | 246 | 243 | 232 | 247 | 278 | 312 | 317 | 384 | 376 | 376 | 375 |
Current Liabilities | 25.2% | 29.00 | 23.00 | 33.00 | 31.00 | 47.00 | 79.00 | 105 | 30.00 | 26.00 | 35.00 | 29.00 | 29.00 | 25.00 | 42.00 | 31.00 | 64.00 | 71.00 | 123 | 82.00 | 52.00 | 59.00 |
Short Term Borrowings | - | - | - | - | - | 14.00 | 43.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt | - | - | - | - | - | - | - | - | 199 | 201 | 180 | 180 | 177 | 174 | 172 | 194 | 191 | 189 | 186 | 184 | 212 | 214 |
LT Debt, Current | - | - | - | - | - | - | 43.00 | 82.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 32.00 | 32.00 | 32.00 | 31.00 | 0.00 | 1.00 |
LT Debt, Non Current | - | - | - | - | - | - | - | - | 199 | 201 | 180 | 180 | 177 | 174 | 172 | 194 | 191 | 189 | 186 | 184 | 212 | 214 |
Shareholder's Equity | -18.1% | 97.00 | 118 | 148 | 166 | 184 | 126 | 143 | 56.00 | 74.00 | 107 | 131 | 159 | 175 | 67.00 | 59.00 | 50.00 | 87.00 | 72.00 | 228 | 279 | 335 |
Retained Earnings | -1.2% | -1,988 | -1,964 | -1,931 | -1,911 | -1,891 | -1,868 | -1,846 | -1,933 | -1,916 | -1,915 | -1,890 | -1,860 | -1,840 | -1,823 | -1,781 | -1,752 | -1,708 | -1,652 | -1,483 | -1,430 | -1,391 |
Additional Paid-In Capital | 0.1% | 2,088 | 2,085 | 2,083 | 2,080 | 2,078 | 1,998 | 1,996 | 1,994 | 1,992 | 2,023 | 2,020 | 2,017 | 2,014 | 1,887 | 1,839 | 1,802 | 1,797 | 1,752 | 1,745 | 1,737 | 1,733 |
Shares Outstanding | 0.5% | 250 | 249 | 256 | 255 | 255 | 208 | 201 | 200 | 200 | 198 | 199 | - | - | - | - | - | - | - | - | - | - |
Minority Interest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.00 |
Float | - | - | - | - | 177 | - | - | - | 162 | - | - | - | 790 | - | - | - | 435 | - | - | - | 660 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 10.6% | -14,090 | -15,766 | -17,008 | -15,768 | -18,388 | -15,396 | -23,813 | -7,053 | -18,783 | -14,589 | -17,022 | -7,776 | -16,384 | -16,469 | -19,004 | -13,805 | -27,743 | -32,142 | -27,148 | -33,403 | -43,234 |
Share Based Compensation | 14.1% | 2,581 | 2,262 | 2,306 | 2,189 | 3,131 | 2,210 | 2,125 | 2,309 | 3,562 | 2,442 | 2,490 | 3,557 | 5,415 | 4,497 | 4,600 | 4,897 | 4,372 | 4,412 | 5,423 | 61.00 | 9,054 |
Cashflow From Investing | 80.9% | 24,045 | 13,293 | 10,525 | 23,503 | -50,408 | 11,421 | 181,855 | 16,573 | 16,568 | 15,929 | 22,013 | 16,620 | -129,102 | 40,184 | 181 | 23,967 | -36,553 | 54,509 | 13,777 | -15,027 | 33,592 |
Cashflow From Financing | - | - | - | - | -14,585 | 44,174 | -39,282 | -115,734 | -113 | -163 | -110 | 234 | 23.00 | 121,040 | -72.00 | -114 | -1,260 | 34,151 | 1,199 | 45.00 | -33.00 | 6,927 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Operating Expenses | |||
Impairment of goodwill | $ 10,390 | $ 482 | $ 0 |
Impairment of other noncurrent assets | 445 | 638 | 543 |
Other Income (expense), Net | |||
Equity in net income (loss) of affiliates | 0 | 862 | (3) |
Loss from continuing operations before income taxes | (96,362) | (79,966) | (110,967) |
Income tax benefit | 458 | 189 | 160 |
Income from discontinued operations, net of income tax benefit | 0 | 108,094 | 18,641 |
Net loss attributable to Precigen | $ (95,904) | $ 28,317 | $ (92,166) |
Net (Loss) Income per Share | |||
Net loss from continuing operations per share, basic (in usd per share) | $ (0.39) | $ (0.40) | $ (0.56) |
Net loss from continuing operations per share, diluted (in usd per share) | (0.39) | (0.40) | (0.56) |
Net income from discontinued operations per share, basic (in usd per share) | 0.00 | 0.54 | 0.09 |
Net income from discontinued operations per share, diluted (in usd per share) | 0.00 | 0.54 | 0.09 |
Net (loss) income per share, diluted (in usd per share) | (0.39) | 0.14 | (0.47) |
Net (loss) income per share, basic (in usd per share) | $ (0.39) | $ 0.14 | $ (0.47) |
Weighted average shares outstanding, basic (in shares) | 244,536,221 | 200,360,821 | 197,759,900 |
Weighted average shares outstanding, diluted (in shares) | 244,536,221 | 200,360,821 | 197,759,900 |
Collaboration and licensing agreements | |||
Revenues | |||
Revenues | $ 75 | $ 14,661 | $ 506 |
Continuing Operations | |||
Revenues | |||
Revenues | 6,225 | 26,909 | 14,267 |
Operating Expenses | |||
Research and development | 48,614 | 47,170 | 47,933 |
Selling, general and administrative | 40,415 | 48,006 | 51,994 |
Impairment of goodwill | 10,390 | 482 | 0 |
Impairment of other noncurrent assets | 445 | 638 | 543 |
Total operating expenses | 105,983 | 102,635 | 106,215 |
Operating loss | (99,758) | (75,726) | (91,948) |
Other Income (expense), Net | |||
Interest expense | (468) | (6,774) | (18,755) |
Interest income | 3,237 | 133 | 171 |
Other income (expense), net | 627 | 1,539 | (432) |
Total other income (expense), net | 3,396 | (5,102) | (19,016) |
Equity in net income (loss) of affiliates | 0 | 862 | (3) |
Loss from continuing operations before income taxes | (96,362) | (79,966) | (110,967) |
Income tax benefit | 458 | 189 | 160 |
Loss from continuing operations | (95,904) | (79,777) | (110,807) |
Continuing Operations | Collaboration and licensing agreements | |||
Revenues | |||
Revenues | 75 | 14,661 | 506 |
Continuing Operations | Product revenues | |||
Revenues | |||
Revenues | 840 | 1,903 | 2,164 |
Continuing Operations | Service revenues | |||
Revenues | |||
Revenues | 5,301 | 10,094 | 11,095 |
Operating Expenses | |||
Cost of product and services | 6,119 | 6,339 | 5,745 |
Continuing Operations | Other revenues | |||
Revenues | |||
Revenues | $ 9 | $ 251 | $ 502 |
Consolidated Balance Sheets - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 7,578,000 | $ 4,858,000 |
Restricted cash | 0 | 43,339,000 |
Short-term investments | 55,277,000 | 51,092,000 |
Receivables | ||
Trade, less allowance for credit losses of $184 as of both December 31, 2023 and 2022 | 902,000 | 978,000 |
Other | 673,000 | 12,826,000 |
Prepaid expenses and other | 4,325,000 | 5,066,000 |
Total current assets | 68,755,000 | 118,159,000 |
Property, plant and equipment, net | 7,111,000 | 7,329,000 |
Intangible assets, net | 40,701,000 | 44,455,000 |
Goodwill | 26,612,000 | 36,923,000 |
Right-of-use assets | 7,097,000 | 8,086,000 |
Other assets | 767,000 | 1,025,000 |
Total assets | 151,043,000 | 215,977,000 |
Current liabilities | ||
Accounts payable | 1,726,000 | 4,068,000 |
Accrued compensation and benefits | 8,250,000 | 6,377,000 |
Other accrued liabilities | 6,223,000 | 4,997,000 |
Settlement and indemnification accrual | 5,075,000 | 18,750,000 |
Deferred revenue | 509,000 | 25,000 |
Current portion of long-term debt | 0 | 43,219,000 |
Current portion of lease liabilities | 1,202,000 | 1,209,000 |
Total current liabilities | 22,985,000 | 78,645,000 |
Long-term portion of deferred revenue | 1,818,000 | 1,818,000 |
Lease liabilities, net of current portion | 5,895,000 | 6,992,000 |
Deferred tax liabilities | 1,847,000 | 2,263,000 |
Total liabilities | 32,545,000 | 89,718,000 |
Commitments and Contingencies | ||
Shareholders' equity | ||
Common stock, no par value, 400,000,000 shares authorized as of December 31, 2023 and 2022; 256,398,527 shares and 208,150,021 shares issued as of December 31, 2023 and 2022, 248,919,096 shares and 208,150,021 shares outstanding December 31, 2023 and 2022, respectively. | 0 | 0 |
Additional paid-in capital | 2,084,916,000 | 1,998,314,000 |
Accumulated deficit | (1,964,471,000) | (1,868,567,000) |
Accumulated other comprehensive loss | (1,947,000) | (3,488,000) |
Total shareholders' equity | 118,498,000 | 126,259,000 |
Total liabilities and shareholders' equity | $ 151,043,000 | $ 215,977,000 |
Common stock, shares outstanding (in shares) | 248,919,096 | 208,150,021 |